FMS Fresenius Medical Care AG Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
13:58
Aug 06
Aug 06
Article names Fresenius as the other largest dialysis operator hit by about 17% after kidney outcomes, implying similar revenue pressure from a smaller kidney-failure population.
Article names Fresenius as the other largest dialysis operator hit by about 17% after kidney outcomes, implying similar revenue pressure from a smaller kidney-failure population.
Risk: Fresenius Medical Care's international mix and non-dialysis businesses may reduce the overall impact.
21:00
Aug 04
Aug 04
DaVita's treatment volume growth is being driven almost entirely by reduced mortality, not new patient starts, and it is outperforming the industry's negative same-store growth. — This confirms DaVita is gaining market share through superior clinical outcomes, a trend that could pressure competitors who cannot replicate the mortality improvements.
HIGH
21:55
Aug 03
Aug 03
Fresenius Medical Care reports second-quarter profit above expectations driven by strong.
Fresenius Medical Care reports second-quarter profit above expectations driven by strong dialysis service unit performance.
12:11
Jul 28
Jul 28
UBS, Stephens, Jefferies, Exane BNP Paribas, TD Cowen, Morgan Stanley, Wells Fargo.
UBS, Stephens, Jefferies, Exane BNP Paribas, TD Cowen, Morgan Stanley, Wells Fargo, Raymond James, and BMO downgraded multiple stocks including ACI, BLFS, CLX, FMS, INSP, INTU, LAUR, LEVI, MPLT, PINE, RXO, SIGI, and XOM with various price target cuts.
11:52
Jul 28
Jul 28
Goldman Sachs upgrades CIB to Buy, KeyBanc upgrades FLY to Overweight.
Goldman Sachs upgrades CIB to Buy, KeyBanc upgrades FLY to Overweight, and multiple other analyst upgrades and downgrades are reported across a wide range of stocks with specific price target changes.
08:30
Jul 23
Jul 23
Quest's partnership with Fresenius is driving volume and expanding its kidney testing portfolio, contributing to revenue growth.
HIGH
21:00
May 05
May 05
DaVita expects to gain dialysis patients from Fresenius clinic closures, with half arriving in Q1 and most of the rest in Q2, contributing positively to 2026 volume growth. — Fresenius's network rationalization is ceding market share to DaVita, a direct transfer of volume and revenue.
HIGH
08:30
Apr 21
Apr 21
Quest provides lab testing for Fresenius dialysis clinics; this relationship contributes significantly to volume but has a dilutive effect on revenue per requisition.
HIGH
08:30
Feb 10
Feb 10
Quest has scaled operations for Fresenius, indicating strong demand for dialysis testing services; Fresenius benefits from Quest's expanded capacity and water purity testing.
HIGH
08:30
Oct 21
Oct 21
Quest has won a large enterprise agreement to serve Fresenius dialysis centers, adding revenue and utilizing excess capacity.
HIGH
About FMS Analyst Coverage
Buzzberg tracks FMS (Fresenius Medical Care AG) across 4 sources. 0 bullish vs 0 bearish calls from 7 analysts. Sentiment: evenly split. 10 total trade ideas tracked. Latest voices: Chamath Palihapitiya, Joel Ackerman, Bloomberg.